J. Goldman & CO LP Mirum Pharmaceuticals, Inc. Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
A detailed history of J. Goldman & CO LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 13,500 shares of MIRM stock, worth $609,525. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,500Holding current value
$609,525% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$297 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$202 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$156 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$146 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$139 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.66B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...